baito logo
    navigation?.buttons?.createJob?.text
    PARI Pharma GmbH header
    PARI Pharma GmbH logo
    #atemwegstherapie #inhalationstherapie #medizinprodukte

    PARI Pharma GmbH

    from Starnberg

    The PARI GmbH is a leading specialist in respiratory therapy based in Starnberg. Since 1906, the company has been developing innovative inhalation devices and solutions that improve the lives of patients worldwide. Quality, user-friendliness, and sustainability are the focus.

    Visit website

    PARI Group: Specialist in Respiratory Therapy

    The PARI Group is a globally recognized specialist in respiratory therapy. Founded in 1906 in Wuppertal, the company has developed into a leading manufacturer of inhalation devices. Today, PARI is headquartered in Starnberg, Germany, with additional locations in Weilheim and Gräfelfing. International subsidiaries and a comprehensive distribution network enable the sale of products in over 80 countries.

    Key Products and Services

    PARI offers a wide range of medical products focused on the diagnosis, prevention, and therapy of respiratory diseases. Among the best-known products are the PARI BOY, synonymous with inhalation therapy, and the eFlow System, which is based on membrane technology. This technology allows for the development of optimized drug-device combinations offered through licensing partnerships.

    Mission and Values

    The mission of PARI is to improve the lives of people with respiratory diseases and their families. The company achieves this through innovative products, tailored solutions, and comprehensive services for patients, medical professionals, and distribution partners. Quality and user-friendliness are paramount.

    Sustainability Goals and Initiatives

    Although specific sustainability goals are not explicitly mentioned, PARI places great importance on quality and innovation. Through continuous research and development, the company contributes to the improvement of respiratory therapy, thereby promoting the health and well-being of patients. The combination of tradition and innovation enables PARI to offer effective and future-proof solutions.

    Current Developments

    PARI recently introduced the PARI Connect System, which supports patients and medical professionals in organizing inhalation therapy. This system includes the eFlow rapid nebulizer with eTrack Controller and the PARI Connect App, which allows for planning and analyzing therapies. This innovative solution promotes closer collaboration between patients and medical professionals, thereby improving the effectiveness of treatment.

    Sources: